What is Bausch Health Companies's legal matters and related fees?

Bausch Health Companies (BHC) reported legal matters and related fees of $28M in Q1 2026.

How has Bausch Health Companies's legal matters and related fees changed year-over-year?

Bausch Health Companies's legal matters and related fees decreased by 91.0% year-over-year, from $310M to $28M.

Revenue$2.5B+11.7%

Operating income-$950.0M-444%

Net income-$1.4B-2,353%

EPS (diluted)-$3.82-2,287%

Cash & equivalents$1.3B+13.4%

Total debt$20.8B-3.5%

Total equity-$2.1B-74.0%

Total assets$24.5B-7.3%

Operating cash flow$230.0M+9.0%

CapEx$109.0M-5.2%

Free cash flow$121.0M+26.0%

Market cap$1.86B-15.9%

Gross margin71.4%—

Operating margin5.6%-10.3pp

Net margin-1.9%-0.9pp

FCF margin9.8%-2.8pp

Return on equity-70.1%—

Debt / equity45.2×—

Current ratio1.3×0.0×

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept bhc:LegalSettlementsAndRelatedFees.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

What is Bausch Health Companies's legal matters and related fees?: Bausch Health Companies (BHC) reported legal matters and related fees of $28M in Q1 2026.
How has Bausch Health Companies's legal matters and related fees changed year-over-year?: Bausch Health Companies's legal matters and related fees decreased by 91.0% year-over-year, from $310M to $28M.